Aktie A2PPRF CELL SOURCE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Cell Source, Inc.

Aktien

A2PPRF

US15114L1044

CLCS

Markt geschlossen - OTC Markets
Andere Börsenplätze
 18:54:58 09.05.2024 		% 5 Tage % 1. Jan.
0.0008 USD +300.00% Intraday Chart für Cell Source, Inc. +300.00% -99.83%
2023 Cell Source, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI
2023 Cell Source, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Cell Source, Inc. announced that it has received $4.76017 million in funding
Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Note 2 - Going Concern and Management Plans
Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Note 2 - Going Concern and Management Plans
Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Note 2 - Going Concern and Management Plans
Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)
Cell Source, Inc. Announces Board Resignations
CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)
Cell Source, Inc. Announces Resigation of Itamar Shimrat as A Director
CELL SOURCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Cell Source, Inc. Auditor Raises 'Going Concern' Doubt
Cell Source, Inc. Appoints George Verstraete as Member
CELL SOURCE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PPRF Aktie
  4. Nachrichten Cell Source, Inc.
  5. Andere Sprachen